0 5

Cited 0 times in

Cited 0 times in

Response to "The Impact of Baseline Comorbidities and Performance Status on HER2-Targeted Therapy Outcomes"

DC Field Value Language
dc.contributor.authorKook, Yoonwon-
dc.contributor.authorAhn, Sung Gwe-
dc.date.accessioned2025-11-06T08:22:45Z-
dc.date.available2025-11-06T08:22:45Z-
dc.date.created2025-08-26-
dc.date.issued2025-06-
dc.identifier.issn1526-8209-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/208397-
dc.languageEnglish-
dc.publisherElsevier Science-
dc.relation.isPartOfCLINICAL BREAST CANCER-
dc.relation.isPartOfCLINICAL BREAST CANCER-
dc.titleResponse to "The Impact of Baseline Comorbidities and Performance Status on HER2-Targeted Therapy Outcomes"-
dc.typeArticle-
dc.contributor.googleauthorKook, Yoonwon-
dc.contributor.googleauthorAhn, Sung Gwe-
dc.identifier.doi10.1016/j.clbc.2025.02.011-
dc.relation.journalcodeJ00562-
dc.identifier.eissn1938-0666-
dc.identifier.pmid40074647-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S1526820925000400-
dc.contributor.affiliatedAuthorKook, Yoonwon-
dc.contributor.affiliatedAuthorAhn, Sung Gwe-
dc.identifier.scopusid2-s2.0-105005471307-
dc.identifier.wosid001498924500006-
dc.citation.volume25-
dc.citation.number4-
dc.citation.startPage390-
dc.identifier.bibliographicCitationCLINICAL BREAST CANCER, Vol.25(4) : 390, 2025-06-
dc.identifier.rimsid88948-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.type.docTypeLetter-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryOncology-
dc.relation.journalResearchAreaOncology-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.